Joenja Tablet, Film Coated
Product Images NDC 71274-170

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Joenja (NDC 71274-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharming Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Joe00 0002 01)

Chemical structure of leniolisib, the active ingredient in Joenja 70 mg oral tablets by Pharming Healthcare Inc. The structure includes a trifluoromethoxy-substituted pyridine ring and a phosphate group (H3PO4) as shown in the diagram.*

FDA Label Image

Figure 1 (Joe00 0002 02)

A forest plot chart comparing Joenja (Leniolisib) 70 mg twice a day versus placebo in human subjects under and over 18 years for two parameters: Log10 transformed SPD and Naive B cells. The chart shows mean differences with 95% confidence intervals, indicating the direction of favor between Joenja and placebo for each age group and overall.*

FDA Label Image

Principal Display Panel – 60 Tablet Carton Label (Joe00 0002 03)

Packaging label for Joenja (leniolisib) tablets 70 mg by Pharming Healthcare Inc. The label shows a carton design with purple and orange colors, stating 60 tablets per container. It includes storage instructions, a barcode, and NDC 71274-170-60. "Rx Only" designation is noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.